A carregar...
Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
Lung squamous cell carcinoma (LSCC) is the most common subtype of non-small cell lung cancer. Immunotherapy has become an effective treatment in recent years, while patients showed different responses to the current treatment. It is vital to identify the potential immunogenomic signatures to predict...
Na minha lista:
| Publicado no: | Front Genet |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485220/ https://ncbi.nlm.nih.gov/pubmed/33005178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00978 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|